US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 3.6000
  • -0.0300-0.83%
Close Nov 1 16:00 ET
  • 4.1680
  • +0.5680+15.78%
Post 19:52 ET
13.73MMarket Cap-534P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NLS Pharmaceutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

NLS Pharmaceutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 22 16:04 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 18 16:35 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 11 07:03 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 25 08:15 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data